Clinical trial · Observational
A Registry for Patients With Systemic Mastocytosis in China
Mastocvtosis Collaborative Network of China: A Registry for Patients With Systemic Mastocytosis
NCT06013683CI-TRIAL-00070331unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The Registry for Patients With Systemic Mastocytosis in China is a voluntary, observational database that will capture demographic, socioeconomic, and disease information with systemic mastocytosis. No experimental intervention is involved.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Systemic Mastocytoses | Systemic Mastocytosis | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- The morbidity rate over 2 years ofSystemic Mastocytosis and its subtypes (cases per 1,000 individuals per year)
- timeFrame
- at 2 year
- description
- Evaluation of the morbidity rate over 2 years of Systemic Mastocytosis and its subtypes including Bone marrow mastocytosis (BMM), Indolent SM, Smoldering SM, Aggressive SM, SM with an associated hematologic neoplasm and Mast cell leukemia. (cases per 1,000 individuals per year)
Secondary outcomes (5)
- measure
- Demographic characteristics of Systemic Mastocytosis
- timeFrame
- at 2 year
- description
- 1. The median age of Systemic Mastocytosis patients (year-old); 2. The sex distribution of Systemic Mastocytosis patients (M/F ratio\[0-1\]); 3. The ECOG score of Systemic Mastocytosis patients (score\[0-5\]); 4. The geographic distribution of Systemic Mastocytosis patients (% per province\[0-100\]);
- measure
- Hematological characteristics of Systemic Mastocytosis
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: 1\. Any patient with a diagnosis of systemic mastocytosis according to World Health Organization (WHO) classification, including subtypes of SM, who is willing and able to provide written online informed consent. Exclusion Criteria: None
References
Publications (0)
Data not yet available
No reference posted for this study.